DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
+8.18%
US · US
CASY.US latest organized financial period shows revenue grew +7.25% YoY and net income grew +8.87% YoY. Current price is about 784 USD, while the model base case is about 469 USD; the current price sits +67.1% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Annual financial metrics with switchable views. · Unit: USD
Price date: 2026/04/29 · Updated: 2026/04/29 15:25
Hover each model row to inspect formulas and inputs.
+67.09%
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
+8.18%
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
+67.09%
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly 17.0% annualized FCF growth.
Estimates earnings power value without assuming growth.
-
Updated: 2026/04/29 15:25
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/04/30 | Asset impairment | Impairment | -3M USD | Medium |
| 2025/04/30 | Asset sale gain/loss | Asset sale gain/loss | -10M USD | Medium |
| 2024/04/30 | Asset impairment | Impairment | -6M USD | Medium |
| 2024/04/30 | Asset sale gain/loss | Asset sale gain/loss | -10M USD | Medium |
| 2023/04/30 | Asset impairment | Impairment | -8M USD | Medium |
| 2023/04/30 | Asset sale gain/loss | Asset sale gain/loss | -16M USD | Medium |
| 2022/04/30 | Asset impairment | Impairment | -3M USD | Medium |
| 2022/04/30 | Asset sale gain/loss | Asset sale gain/loss | 3M USD | Medium |
| 2021/04/30 | Asset impairment | Impairment | -9M USD | Medium |
| 2021/04/30 | Asset sale gain/loss | Asset sale gain/loss | -23M USD | Medium |
| 2020/04/30 | Asset impairment | Impairment | -3M USD | Medium |
| 2020/04/30 | Asset sale gain/loss | Asset sale gain/loss | -8M USD | Medium |
| 2026/01/31 | Asset sale gain/loss | Asset sale gain/loss | -3M USD | Medium |
| 2025/10/31 | Asset sale gain/loss | Asset sale gain/loss | -1M USD | Medium |
| 2025/07/31 | Asset sale gain/loss | Asset sale gain/loss | -443K USD | Medium |
| 2025/01/31 | Asset sale gain/loss | Asset sale gain/loss | -14M USD | Medium |
| 2024/10/31 | Asset sale gain/loss | Asset sale gain/loss | -7M USD | Medium |
| 2024/07/31 | Asset sale gain/loss | Asset sale gain/loss | -4M USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/04/30 | Annual | 16B USD | 547M USD | 560M USD | 585M USD | 14.64 | 14.99 |
| 2024/04/30 | Annual | 15B USD | 502M USD | 519M USD | 371M USD | 13.43 | 13.87 |
| 2023/04/30 | Annual | 15B USD | 447M USD | 471M USD | 405M USD | 11.91 | 12.57 |
| 2022/04/30 | Annual | 13B USD | 340M USD | 339M USD | 462M USD | 9.1 | 9.09 |
| 2021/04/30 | Annual | 9B USD | 313M USD | 345M USD | 363M USD | 8.38 | 9.24 |
Total revenue recognized in each fiscal year.
Adjusted close trend. Current price sample covers: 2025/04/16 - 2026/04/29.